Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
GLP-1 Providers That Accept Health Net: 2026 Coverage & Provider Guide
By The RX Index Editorial Team
Published: · Last reviewed:
Last verified: against Health Net clinical policies HNCA.CP.CPA.352 and HNCA.CP.CPA.359, Medi-Cal Rx 2026 budget update, and CMS Medicare GLP-1 Bridge documentation.
Ro contacts your insurer and generates a personalized Wegovy, Zepbound, or Foundayo coverage report. No membership required to get the report.
The honest answer first: Most national GLP-1 telehealth platforms don't bill Health Net for the visit the way an in-network doctor's office does. Shapely is the Health-Net-specific telehealth exception we found, and every provider still has to be verified against your exact plan. So when you search “GLP-1 providers that accept Health Net,” what you're really asking is one of four different questions — and the right provider depends on which one fits you. We'll show you which.
If you have commercial Health Net (employer plan, Marketplace/Ambetter, small group, large group) and your real bottleneck is medication coverage and prior authorization, Ro is the strongest fit — it can check your insurance, generate a personalized coverage report, and submit prior-authorization paperwork to Health Net.
If your real bottleneck is getting the visit itself billed in-network, Shapely is the only major telehealth provider we found with a Health-Net-specific weight-loss page (PPO members in particular).
If you're on Health Net Medi-Cal, brace yourself: as of January 1, 2026, Medi-Cal Rx no longer covers GLP-1 drugs for weight-loss-only indications in adults 21 and older. Some non-weight-loss indications and under-21 EPSDT cases still have separate paths.
If you're on Health Net Medicare Advantage with drug coverage (an MA-PD plan), the federal Medicare GLP-1 Bridge begins July 1, 2026 for eligible Part D beneficiaries — a flat $50/month copay for Wegovy, Zepbound KwikPen, and Foundayo through December 31, 2027.
(sponsored affiliate link, opens in a new tab)Your situation → start here
Before you book anything or pay any membership fee, find your row in this table. Most readers are in row 1.
| What you actually need | Start here | Why |
|---|---|---|
| The medication covered + PA handled (most common) | Ro's free GLP-1 Insurance Coverage Checker (sponsored affiliate link, opens in a new tab) | Strongest verified insurance-concierge route for commercial Health Net members; offers Wegovy pen, Wegovy pill, Zepbound KwikPen, and Foundayo |
| The visit billed in-network (PPO especially) | Health Net's Find a Provider tool + verify Shapely | Only Health-Net-specific telehealth weight-loss page we found |
| Help with insurance + obesity-specialist care | Form Health or knownwell | Built around insurance-based obesity medicine |
| Mainstream telehealth + PA help | PlushCare (sponsored affiliate link, opens in a new tab) | Accepts most major insurance, helps with PA (verify your exact plan) |
| Lifestyle program documentation Health Net requires | WeightWatchers Clinic | Health Net's policies cite Weight Watchers and Active&Fit as approved programs |
| Health Net Medi-Cal weight-loss only | Take the quiz first — coverage was terminated 1/1/2026 for adults 21+ | Don't pay a cash-pay program before you understand your real options |
| Cash-pay FDA-approved fallback if denied | Sesame Care (Costco partnership) (sponsored affiliate link, opens in a new tab), Ro cash-pay, NovoCare, or LillyDirect | All list current self-pay GLP-1 prices |
The four-question test (this is where most people get stuck)
Pause for ten seconds. “Does this provider accept Health Net?” is actually four separate questions blurred into one. Knowing which one you're really asking is the difference between a smooth path and weeks of wasted time and money.
Question 1 — Will Health Net pay the provider for the visit?
This is the only “in-network” question. Most national GLP-1 telehealth platforms (Ro, Hims, Sesame, Found, MEDVi) do not bill Health Net for visits. Their visits are wrapped into a flat membership fee you pay yourself. Shapely is the exception we found.
Question 2 — Will Health Net pay the pharmacy for the medication?
This is where most of the real money is. Wegovy and Zepbound list prices are roughly $1,350 and $1,086 per month. Whether your pharmacy bill becomes $25 or $1,300 depends on your Health Net pharmacy benefit, your BMI, your plan group, your diagnosis, and your prior authorization — not on which telehealth provider you used.
Question 3 — Will the provider handle the prior authorization (PA)?
Health Net requires PA for every GLP-1 prescribed for weight loss. PA approval depends on documentation: BMI within 30 days, six months of participation in a Health Net-approved weight-loss program, follow-up plan, and (if you have type 2 diabetes) records of failed trials of other GLP-1s. A provider that handles PA well is worth more than one with a flashier app.
Question 4 — What's your cash-pay fallback if Health Net denies you?
For Marketplace/Ambetter and many Standard Coverage Large Group plans, Health Net now requires BMI ≥40 for new weight-loss prescriptions. Plenty of legitimate candidates with BMI 30–39 will be denied. Know your fallback before you start.
Once you know which question is yours, the right provider is obvious. Most people are asking Question 2 + Question 3 — that's where Ro shines. If you're really asking Question 1, we'll show you Shapely below.
Health Net GLP-1 coverage in 2026: what your plan actually covers
The short version: Health Net (a Centene company) operates four very different plan types in California. Marketplace/Ambetter and most Standard Coverage Large Group plans now require BMI ≥40 for new weight-loss prescriptions. Small Group and Enhanced Large Group plans cover BMI ≥30, or ≥27 with a comorbidity. Medi-Cal stopped covering weight-loss GLP-1s on January 1, 2026 for adults 21 and older. Medicare Advantage members with drug coverage can access $50/month coverage starting July 1, 2026 through the federal Medicare GLP-1 Bridge.
Built from Health Net of California clinical policies HNCA.CP.CPA.352 (Wegovy, last reviewed March 2026) and HNCA.CP.CPA.359 (Zepbound, last reviewed February 2026), plus the Medi-Cal Rx 2026 budget update and CMS Medicare GLP-1 Bridge documentation. Members outside California should verify their own plan documents.
| Health Net plan type | Eligible for weight-loss coverage? | BMI requirement | Lifestyle program required? | Initial approval | Renewal |
|---|---|---|---|---|---|
| Commercial — Large Group Enhanced | Eligible with PA — Wegovy injection, Wegovy pill, Zepbound | BMI ≥30, or ≥27 with one comorbidity (HTN, dyslipidemia, T2DM, sleep apnea, CVD) | 6 months active participation in Health Net-approved program (Weight Watchers, Active&Fit) before starting | Up to 16 weeks | ≥5% body weight loss at first renewal; ongoing loss/maintenance after |
| Commercial — Large Group Standard | Eligible with PA if benefit applies | BMI ≥40 (no comorbidity exception) | 6 months active participation in Health Net-approved program | Up to 16 weeks | ≥5% body weight loss at first renewal |
| Commercial — Small Group | Eligible with PA if benefit applies | BMI ≥30, or ≥27 with comorbidity | 6 months active participation in Health Net-approved program | Up to 16 weeks | ≥5% body weight loss at first renewal |
| Marketplace / Ambetter from Health Net | Eligible with PA if benefit applies | BMI ≥40 for new prescriptions | 6 months active participation | Up to 16 weeks | ≥5% body weight loss at first renewal |
| Health Net Medi-Cal | No — terminated January 1, 2026 for adults 21 and older. Still covered for: T2DM, Wegovy for MASH (no PA after April 1, 2026), Wegovy for established CVD (PA required), Zepbound for moderate-to-severe OSA (PA required), EPSDT case-by-case for members under 21 | Not applicable for weight loss | Not applicable for weight loss | Not applicable for weight loss | Not applicable for weight loss |
| Health Net Medicare Advantage with drug coverage (MA-PD) | Starting July 1, 2026 — $50/month copay through December 31, 2027 via Medicare GLP-1 Bridge (Wegovy injection & tablets, Zepbound KwikPen, Foundayo) | BMI ≥35; OR ≥30 with HFpEF, uncontrolled HTN, or CKD 3a+; OR ≥27 with prediabetes, prior MI, prior stroke, or symptomatic PAD | Set by Bridge program | Set by Bridge program | Set by Bridge program |
| Compounded semaglutide / tirzepatide (any Health Net plan) | No. Explicitly excluded under HNCA.CP.CPA.352 and HNCA.CP.CPA.359 | Not applicable | Not applicable | Not applicable | Not applicable |
A few details that matter:
- The 16-week initial approval means your provider is repeating the PA roughly every four months. A provider that does PA badly creates a recurring problem, not a one-time problem.
- The “6 months of active participation in a Health Net-approved weight-loss program” rule is the single most-missed criterion. Health Net specifically names Weight Watchers and Active&Fit in its policies. If you're not enrolled in something documentable, fix that before you ask for PA.
- The renewal trap: at first renewal, you must show ≥5% weight loss from baseline. People who reach maintenance and stop losing weight have lost coverage at renewal time. Document everything.
- For members with type 2 diabetes who want Wegovy or Zepbound, Health Net requires documented trials of ≥3 months each on Ozempic or Rybelsus, Trulicity, generic Victoza (liraglutide), and Mounjaro before approval — unless contraindicated.
- Some PPO plans may not have weight-loss medication coverage at all, and some employers may purchase enhanced or reduced benefits. Verify with your specific plan documents or member services.
Health Net GLP-1 Coverage Path Finder
A few quick questions about your plan, BMI, diagnosis, and situation — and we return a personalized result: which medications are likely approvable, which provider workflow fits, what documents to gather, and a realistic monthly cost range. We don't ask for your insurance card, your name, or your medical record.
Open the Coverage Path Finder — Free →Which GLP-1 providers that accept Health Net should commercial members compare first?
For a Health Net member with a commercial plan (employer, Small Group, Large Group, or Ambetter Marketplace) who wants to use insurance to pay for Wegovy, Zepbound, or Foundayo, four providers stand out for different reasons. Most readers should start with Ro for the medication-coverage question.
1. Ro — best for medication coverage + prior authorizationOur primary recommendation
What Ro does that matters here: Ro's free GLP-1 Insurance Coverage Checker contacts your insurance company and generates a personalized report on whether your plan covers Wegovy, Zepbound, or Foundayo before you pay anything. Then Ro's insurance concierge — a real team, not a chatbot — submits the prior authorization to Health Net for you, follows up with the insurer, and explores other covered options if the first request is denied. Ro says the full insurance process typically takes about 2–3 weeks.
Pricing: Get started for $39 the first month, then $149/month, or as low as $74/month with the annual plan paid upfront. The Ro Body membership is separate from your medication cost — Health Net pays the pharmacy for the medication itself if your PA is approved.
FDA-approved options: Foundayo (orforglipron), Wegovy pill, Wegovy pen, Zepbound pen, and Zepbound KwikPen. Ro also matches LillyDirect, NovoCare, and TrumpRx pricing on cash-pay options.
Planning example: A Marketplace/Ambetter member with BMI 41 whose Wegovy PA is approved and whose deductible is met would pay roughly $149/month for Ro plus their actual Health Net pharmacy copay. Ro says GLP-1 copays vary by plan and the final number may not be known until pharmacy pickup — which is why the free coverage check matters.
One real flaw, said plainly: Ro does NOT bill Health Net for the Ro Body membership. If your top priority is having the visit itself billed in-network, Shapely is a better fit for Health Net PPO members specifically. But because Ro doesn't try to bill insurance for visits, it can put all of its energy into the part that actually moves your bill from $1,300/month to your copay: the prior authorization.
“Within two days, Ro ran my prior authorization and guided me to a savings card. When I went to CVS to pick up my prescription, it was just $25.” — Ro paid-partner member story, ro.co/weight-loss/coverage-checker-report
Best for:
- Health Net Commercial members wanting Wegovy, Zepbound, or Foundayo coverage checked
- People who need PA paperwork handled
- People who want a free coverage report before paying
Not for:
- Medi-Cal members seeking weight-loss coverage (no longer available)
- Medicare Advantage members before July 1, 2026
- People whose only goal is cheapest possible compounded GLP-1
2. Shapely — best if you specifically need the visit billed in-network (PPO members)
Why Shapely is here: Of every major telehealth GLP-1 platform, Shapely is the only one we found with a Health-Net-specific weight-loss page. They state they're in-network with Health Net for weight loss and describe support for eligible PPO members, prescriptions, and pharmacy access. That's a meaningful difference from a generic “we accept most insurance” claim.
What to verify before booking:
- Your exact Health Net plan name (off your member ID card)
- HMO vs PPO (Shapely emphasizes PPO members)
- Whether Shapely shows up in Health Net's Find a Provider tool when you select your exact plan
- Whether your medication coverage is separate from your visit coverage (it is — that's Question 2)
- Whether labs and medication are bundled or separate
3. Form Health and knownwell — best for obesity-specialist insurance care
Form Health says it's in-network with national insurance plans, accepts most major private insurance and Medicare, and helps members with prior authorization. Their model is built around board-certified obesity medicine physicians — a heavier-clinical, less-consumer-app feel.
knownwell says it works with most major commercial plans, accepts Medicare, and notably has no membership fees beyond what your insurance covers. That's rare in this category.
Best for: Members who want a clinical-feel obesity medicine practice and don't mind verifying their exact Health Net plan with the provider before booking.
Verify before booking: Search Find a Provider with your exact plan, or ask the provider's intake team to confirm in writing that they're in-network for your specific Health Net plan.
4. PlushCare and WeightWatchers Clinic — situational fits
PlushCare (sponsored affiliate link, opens in a new tab) says it accepts most major insurance plans (not Medicaid) and that its clinical team helps with prior authorization for GLP-1 medications. It's a strong mainstream-telehealth option for general primary care plus PA support, but Health-Net-specific acceptance is something you need to verify directly.
WeightWatchers Clinic matters for one specific reason: Health Net's clinical policies explicitly name Weight Watchers as an approved weight-loss program for the 6-month documentation requirement. If you're already in WW or thinking about it, the WW Clinic add-on means your lifestyle-program documentation and your GLP-1 prescription come from the same place — a clean PA file.
Provider comparison table — Health Net angle
| Provider | Bills Health Net for visits? | Helps with PA? | FDA-approved options | Membership | Best for |
|---|---|---|---|---|---|
| Ro | No (cash-pay membership) | Yes — dedicated insurance concierge | Foundayo, Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen | $39 first month, $149/mo or as low as $74/mo annual | Most Health Net Commercial members |
| Shapely | Yes for eligible Health Net PPO weight-loss plans (verify your exact plan) | Yes | Wegovy, Zepbound, plus self-pay options | Variable by plan | PPO members who specifically need the visit billed in-network |
| Form Health | Yes for in-network plans (verify) | Yes | Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda | Insurance-billed; verify | Obesity-specialist clinical care |
| knownwell | Yes for in-network plans (verify) | Yes | Brand-name FDA-approved | No membership fee beyond insurance | Members who want zero extra membership cost |
| PlushCare | Yes for most major insurance (Medicaid not accepted; verify Health Net) | Yes | Brand-name FDA-approved | Membership + insurance billing | Mainstream telehealth + PA help |
| WeightWatchers Clinic | Variable — verify directly | Yes | Wegovy, Zepbound, Saxenda, metformin, naltrexone/bupropion | Membership + insurance billing | Members who need the 6-month lifestyle-program documentation Health Net requires |
| Sesame Care | No (cash-pay, but Costco-member discount at Costco Pharmacy) | Provider-driven (varies) | Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda, Trulicity, Rybelsus, Victoza, Contrave, metformin | $59/mo annual or $179/quarter Costco plan | Cash-pay backup, Costco members |
Most Health Net Commercial members will start with Ro for the coverage check, then add Shapely or an in-network specialist if they need the visit itself billed.
Run Ro's Free Coverage Report → (sponsored affiliate link, opens in a new tab)How Health Net's prior authorization actually works (the criteria most pages skip)
Bottom line: Health Net of California's clinical policies HNCA.CP.CPA.352 (Wegovy) and HNCA.CP.CPA.359 (Zepbound) define exactly what your provider must document for PA to succeed. Five things get most denials: BMI below your plan's threshold, missing six-month lifestyle program documentation, missing required GLP-1 trials for type 2 diabetes members, missing weight documentation within the last 30 days, and no follow-up visit plan.
The full Health Net PA checklist for Wegovy and Zepbound
| # | PA requirement | Detail |
|---|---|---|
| 1 | Documented current height and weight | Measured within the last 30 days. Not an estimate — a real measurement, recent. |
| 2 | BMI meets your plan's threshold | Marketplace/Ambetter, Standard Coverage Large Group: BMI ≥40. Enhanced Coverage Large Group, Small Group: BMI ≥30, or ≥27 with at least one cardiovascular risk factor (HTN, dyslipidemia, T2DM, elevated waist circumference, sleep apnea). |
| 3 | Member is 18 or older | Wegovy injection allows 12+ for adolescent obesity. Wegovy tablet is adults only. |
| 4 | Six months of active participation | In a Health Net-approved weight-loss program before starting the GLP-1. Health Net specifically names Weight Watchers and Active&Fit. Your prescriber's documented lifestyle plan also qualifies. |
| 5 | Continued enrollment | In the weight-loss program throughout treatment. |
| 6 | Follow-up visit plan | Prescriber must attest in writing that follow-ups are scheduled to assess adherence and response. |
| 7 | Not concurrently prescribed another GLP-1 | Cannot be on another GLP-1 receptor agonist or another tirzepatide product simultaneously. |
| 8 | For type 2 diabetes members | Documented trial of ≥3 consecutive months each of Ozempic or Rybelsus, Trulicity, generic Victoza (liraglutide), and Mounjaro before Wegovy or Zepbound is approved — unless contraindicated or clinically significant adverse effects occurred. Common GI side effects don't count. |
| 9 | Dose follows titration schedule | Week-by-week ramp-up matters for PA approval. |
Initial approval is only 16 weeks — the renewal trap
Health Net's initial PA approval lasts up to 16 weeks — about four months. You will go through this paperwork again, and again. At first renewal, your prescriber must document that you've lost ≥5% of your baseline body weight. At second and subsequent renewals, you must show ongoing weight loss or maintenance. A provider who handles PA well isn't optional — it's the whole game.
Documents to gather before you start any provider
- Current weight (within 30 days) and current height
- BMI calculated from those (BMI = 703 × [weight in lbs / height in inches²])
- Health Net member ID card with exact plan name
- Records of weight-loss program participation for the last 6 months (Weight Watchers receipts, Active&Fit history, dietitian visits, PCP visit notes)
- Diagnosis records (T2DM, hypertension, sleep apnea, CVD, dyslipidemia — whatever applies)
- If switching from another GLP-1: prescription history showing the switch and the medical reason
You can read Health Net's policies yourself: Wegovy PA policy (HNCA.CP.CPA.352) and Zepbound PA policy (HNCA.CP.CPA.359).
Have your documents ready and want to move fast? Ro's concierge will handle the PA submission for you once you're in.
Start Your Free Coverage Report → (sponsored affiliate link, opens in a new tab)Health Net Medi-Cal members: what changed January 1, 2026 (and what to do now)
The hard part:
California's Medi-Cal Rx program ended GLP-1 coverage for weight loss and weight-loss-related indications on January 1, 2026 — for adults 21 and older, regardless of BMI. All previously approved Wegovy, Zepbound, and Saxenda PAs for adult weight loss expired December 31, 2025. Hundreds of thousands of Californians lost coverage overnight.
One important continuation path most pages miss:
If you received a Notice of Action and request a State Hearing within the timeframe listed in the notice, Medi-Cal Rx says you may continue receiving the GLP-1 while the hearing is pending — until the earlier of your current PA period ending, the State Hearing decision, or the hearing being withdrawn or closed. State Hearing requests go through CDSS at P.O. Box 944243, MS 21-37, Sacramento, CA 94244-2430.
What's still covered for Medi-Cal members:
- Type 2 diabetes — any GLP-1 on the Medi-Cal Rx Contract Drug List (Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon, Trulicity)
- Wegovy for MASH (metabolic dysfunction-associated steatohepatitis) — effective April 1, 2026, no PA required if billed with the proper ICD-10 (K76.0 or K75.8)
- Wegovy for established cardiovascular disease — PA required
- Zepbound for moderate-to-severe obstructive sleep apnea — PA required
- Members under 21 — case-by-case review under the federal EPSDT benefit
Your real options as a Medi-Cal member
1. If your prescription was actually for diabetes, CVD, MASH, or OSA: Talk to your in-network Medi-Cal provider about getting the PA submitted with the correct ICD-10. The drug may still be covered — it's the indication that matters now.
2. If you got a Notice of Action and want to keep your medication while you fight it: Request a State Hearing within the timeframe in your notice.
3. If weight loss is your only indication and a State Hearing isn't an option: Cash-pay is your honest next step. The cash-pay options to compare first:
- Wegovy pen at NovoCare: $199 for each of the first two monthly fills through June 30, 2026, then $349/month standard or $399/month HD, subject to eligibility
- Wegovy injection through Sesame/Costco partnership (Costco membership required): ~$349/month
- Zepbound at LillyDirect: starts at $299/month for KwikPen or vial 2.5 mg; higher maintenance doses run $399–$549/month
- Foundayo (oral) at LillyDirect or Ro: starting at $149/month at the lowest dose
4. If you're under 21: Your prescriber can submit a PA under the EPSDT benefit. Outcomes vary case-by-case — but that path exists.
Just lost Medi-Cal coverage and don't know what to do next? We'll send you a personalized action plan based on your situation, not a sales pitch.
Take Our Free 60-Second Quiz →Health Net Medicare Advantage and the Medicare GLP-1 Bridge: $50/month from July 1, 2026
The short version: Beginning July 1, 2026, eligible Medicare Part D beneficiaries — including Health Net Medicare Advantage members enrolled in MA-PD plans — can access Wegovy (injection and tablets), Zepbound KwikPen, and Foundayo for a flat $50/month copay through the federal Medicare GLP-1 Bridge if they meet CMS prior-authorization criteria. The program runs through December 31, 2027.
Eligibility — one of three CMS pathways
| Pathway | Eligibility criteria |
|---|---|
| Pathway 1 | BMI ≥35 (any comorbidity status) |
| Pathway 2 | BMI ≥30 plus heart failure with preserved ejection fraction (HFpEF), uncontrolled hypertension, or chronic kidney disease stage 3a or above |
| Pathway 3 | BMI ≥27 plus prediabetes, prior myocardial infarction, prior stroke, or symptomatic peripheral artery disease |
What's covered (and what's not)
| Category | Medications |
|---|---|
| Covered through the Bridge | All formulations of Foundayo, all formulations of Wegovy (injection and tablets), and the KwikPen formulation of Zepbound only |
| NOT covered through the Bridge | Zepbound single-dose vials and Zepbound single-dose pens |
| Not covered for weight loss | Mounjaro, Ozempic, Rybelsus (covered under standard Medicare Part D for type 2 diabetes only) |
What to do between now and July 1, 2026
- Verify your enrollment. You need to be in a standalone Part D plan (PDP) or a Medicare Advantage plan with drug coverage (MA-PD).
- Document your comorbidities. Get current records of any HFpEF, hypertension, CKD, prediabetes, prior MI, prior stroke, or PAD diagnosis.
- Talk to your provider. Have BMI documentation ready and discuss whether you'll qualify under one of the three pathways.
- Watch for CMS updates on the central-processor PA submission process. Details are expected in Spring 2026.
When the Bridge launches, telehealth providers like Ro that already operate insurance concierge teams are likely to have a smooth workflow for submitting Bridge PAs. We'll update this page within 48 hours of program launch. Note also: CMS announced on April 21, 2026 that the BALANCE Model will not be implemented in Medicare Part D as planned, and the Bridge has been extended through 2027. Coverage beyond 2027 is uncertain.
Medicare Advantage member preparing for July 1? We'll show you what to gather now so your PA is ready to submit on day one.
Take Our Free Quiz →What if Health Net denies your prior authorization?
A Health Net denial is rarely the end of the road, but the right next step depends on the denial reason.
| Denial reason | What it actually means | Your next move |
|---|---|---|
| BMI below plan threshold | Your specific Health Net plan requires a higher BMI than yours (likely BMI ≥40 on Marketplace/Standard Large Group) | If you have a comorbidity, ask your prescriber whether your plan has an enhanced rider. If not, it's a cash-pay path. |
| Missing 6-month weight-loss program documentation | Health Net needs paperwork showing you participated in an approved program before requesting the GLP-1 | Enroll in Weight Watchers or Active&Fit now. Document for 6 months. Resubmit. |
| Missing required GLP-1 trials (T2DM members) | You have type 2 diabetes and Health Net wants 3-month trials of Ozempic, Trulicity, Victoza, and Mounjaro first | Discuss the sequence with your prescriber. Some prior trials may already exist in your record. |
| Missing 30-day weight documentation | The most common avoidable denial — your weight needs to be measured within the last 30 days | Get an in-person visit, document weight, resubmit. |
| No follow-up visit plan | Prescriber didn't document follow-up scheduling | Quick fix — prescriber attestation, resubmit. |
| Plan exclusion (employer dropped GLP-1 coverage) | Some employer plans purchase reduced benefits that exclude weight-loss medications entirely | If your benefit document explicitly excludes weight-loss medications, an appeal is unlikely to create coverage. Cash-pay path. |
| Medi-Cal weight-loss-only denial | Medi-Cal Rx no longer covers weight-loss GLP-1s for adults 21+ as of 1/1/2026 | If you have a covered indication (T2DM, MASH, CVD, OSA), resubmit with that diagnosis. Otherwise, request a State Hearing if eligible, or move to cash-pay. |
| Compounded medication request | Health Net excludes compounded medications from coverage | Either request an FDA-approved alternative, or pursue compounded as a cash-pay path with another provider. |
How to appeal in California
- Internal appeal with Health Net — file by the deadline listed in your denial notice. Have your prescriber write a letter of medical necessity.
- Independent Medical Review (IMR) through the California Department of Managed Health Care (DMHC) — free for consumers. According to the DMHC 2024 Annual Report, approximately 73% of IMR cases resulted in the enrollee receiving the requested service or treatment. Note: benefit exclusions may be handled as Consumer Complaints rather than IMRs.
- Switch providers if your current provider's PA documentation isn't strong enough. A provider with an experienced insurance team (Ro's concierge, Form Health's clinical team) often gets PAs approved that another provider's paperwork couldn't.
Got denied and not sure if it's worth appealing? We'll tell you whether your denial is fixable, and what to do about it if it's not.
Take Our 60-Second Quiz →Realistic monthly cost: Health Net + telehealth + medication
The short version: For a Health Net Commercial member whose PA gets approved, real all-in monthly cost is your provider fee plus your actual Health Net pharmacy copay. Ro membership runs $149/month (or as low as $74/month with annual prepay). For a denial-and-cash-pay path, expect $299–$1,086/month for brand-name medication plus the membership fee.
These are planning estimates, not verified Health Net quotes. Your actual numbers depend on your plan tier, deductible status, and the medication your provider prescribes.
| Scenario | Planning estimate | What's in it |
|---|---|---|
| Marketplace/Ambetter member, BMI 41, Wegovy approved, deductible met | ~$149 + your Wegovy copay | Ro $149 membership + Health Net pharmacy copay (varies by plan) |
| Small Group member, BMI 32 with HTN, Zepbound approved, deductible NOT yet met | High first months → drops sharply once deductible met | Ro $149 + Zepbound applied to deductible until met, then standard copay |
| Large Group Standard, BMI 36 with sleep apnea, denied for weight loss | ~$408/mo | Sesame $59 (annual) + Costco-Sesame Wegovy $349 |
| Medi-Cal member, BMI 35 weight loss only | ~$408/mo (no insurance applies) | Sesame $59 + Costco-Sesame Wegovy $349 |
| Medicare Advantage member after July 1, 2026, BMI 35 approved | $50/mo | Bridge program flat copay |
| Cash-pay compounded fallback | Advertised $99–$349/mo | Membership fee + compounded medication (not FDA-approved; pricing must be verified) |
“Covered” doesn't always mean “cheap.” A Health Net plan can technically cover Wegovy and still leave you paying hundreds per month until you hit your deductible. The free coverage report from Ro shows you the real number for your plan.
Cash-pay backup paths if Health Net won't cover you
If your Health Net PA was denied or your plan excludes weight-loss medications, four cash-pay routes are worth knowing. FDA-approved cash-pay and compounded GLP-1s are different categories — Health Net policies exclude compounded medications from coverage on every plan.
FDA-approved cash-pay options
| Option | Price | Details |
|---|---|---|
| Sesame Care + Costco Pharmacy (sponsored affiliate link, opens in a new tab) | ~$349/mo Wegovy; $59/mo annual membership | Costco members can get Wegovy or Ozempic injections at Costco Pharmacy. Broadest cash-pay formulary — Wegovy injection, Wegovy pill, Zepbound vials/pens, Ozempic, Mounjaro, Foundayo, Saxenda, Victoza, Trulicity, Rybelsus, Contrave, metformin |
| Ro cash-pay (sponsored affiliate link, opens in a new tab) | $39 first month, $149/mo ongoing or $74/mo annual | Skip the insurance step — Ro matches LillyDirect, NovoCare, and TrumpRx pricing on the medication itself |
| NovoCare (direct from Novo Nordisk) | $199 first two fills; $349/mo standard or $399/mo HD through June 30, 2026 | Wegovy pen pricing, subject to eligibility and program restrictions |
| LillyDirect (direct from Eli Lilly) | $299/mo starting (Zepbound 2.5 mg); Foundayo from $149/mo | Zepbound 2.5 mg is a starting dose only — not approved as a maintenance dose. Higher maintenance doses are priced higher |
Compounded GLP-1s — what to know if you're considering them
Compounded semaglutide and compounded tirzepatide are prescription medications prepared by licensed compounding pharmacies. They are not FDA-approved. On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List — which would significantly tighten the legal basis for bulk compounding. That regulatory landscape is shifting fast.
Health Net does not cover compounded GLP-1s on any plan. Some programs advertise $99–$349/month, but pricing, pharmacy source, state availability, and regulatory status must be verified before relying on any provider. If you choose this path, verify the pharmacy's licensure, the state availability, the cancellation terms, and the FDA's current guidance.
Denied by Health Net and not sure which cash-pay path fits? We'll route you to the right comparison without forcing you into the wrong category.
Take Our Free 60-Second Quiz →Pre-booking: the 7-step Health Net verification checklist
- Find your exact Health Net plan name on your member ID card. Not “Health Net” — the specific plan (e.g., “Health Net PPO Blue & Gold,” “Ambetter Clear from Health Net Silver,” “Health Net Medi-Cal HMO,” “Health Net Seniority Plus HMO”).
- Identify your plan type: HMO, PPO, IFP/Ambetter, Small Group, Large Group, Medi-Cal, or Medicare Advantage (with or without drug coverage).
- Use Health Net's Find a Provider tool with your exact plan selected. Provider participation depends on the exact plan — selecting “Health Net” generically is not enough.
- Check your pharmacy benefit and formulary. Wegovy and Zepbound formulary status differs by plan group and can change quarterly.
- Call the member services number on your card and ask: “Does my pharmacy benefit cover Wegovy [or Zepbound or Foundayo] for my diagnosis? Is prior authorization required? What BMI threshold does my specific plan require?”
- Gather your documents: recent height/weight (within 30 days), BMI, diagnosis records, any prior weight-loss program participation records.
- Choose your provider route: Medication coverage + PA help → Ro. Visit billed in-network (PPO) → Shapely (verify in Find a Provider). Insurance-based obesity-specialist care → Form Health or knownwell. Denied or excluded → cash-pay backup or quiz.
Script you can copy-paste when calling Health Net:
“Hi — I'm trying to understand GLP-1 coverage under my Health Net plan. Can you confirm whether my pharmacy benefit covers Wegovy, Zepbound, Saxenda, Ozempic, Mounjaro, or Foundayo for my diagnosis? Do I need prior authorization? What BMI threshold does my specific plan require? What weight-loss program documentation is needed? Is my preferred provider in-network for this exact plan?”
Script for the telehealth provider before you pay:
“Do you bill Health Net for the visit, or is this a cash-pay membership? Do you handle prior authorization for Health Net, or does my prescription get sent to my pharmacy and the PA is on me? Can you document BMI, weight-loss program participation, and diagnosis requirements? What's your process if Health Net denies the medication?”
Got your documents and want to skip the phone calls? Ro contacts your insurance company to complete the personalized coverage report for you.
Run Ro's Free Health Net Coverage Report → (sponsored affiliate link, opens in a new tab)Frequently asked questions
Does Health Net cover Wegovy in 2026?+
Does Health Net cover Zepbound in 2026?+
Does Health Net cover Foundayo?+
Does Health Net cover Ozempic for weight loss?+
What GLP-1 telehealth providers actually accept Health Net?+
Does Ro accept Health Net?+
Does Shapely accept Health Net?+
How long does Health Net prior authorization take for GLP-1 medications?+
What BMI does Health Net require for Wegovy or Zepbound?+
Does Health Net require a weight-loss program before approving a GLP-1?+
Does Health Net cover compounded semaglutide or compounded tirzepatide?+
Does Health Net Medi-Cal cover GLP-1s for weight loss?+
Does Health Net Medicare Advantage cover Wegovy?+
What documents do I need for Health Net prior authorization?+
What we actually verified to write this page
We pulled Health Net's coverage rules directly from the source so you don't have to. Here's what we read and when:
| Source | Accessed |
|---|---|
| Health Net of California Wegovy clinical policy HNCA.CP.CPA.352 — last reviewed by Health Net March 2026 | May 4, 2026 |
| Health Net of California Zepbound clinical policy HNCA.CP.CPA.359 — last reviewed by Health Net February 2026 | May 4, 2026 |
| Health Net 2026 weight-loss medication coverage criteria bulletin (IFP/Ambetter and Standard Large Group BMI ≥40 changes) | May 4, 2026 |
| Medi-Cal Rx GLP-1 Coverage Considerations bulletin (effective 1/1/2026) and State Budget Policy Updates FAQ | May 4, 2026 |
| CMS Medicare GLP-1 Bridge program documentation (last updated by CMS April 6, 2026, including Foundayo addition) | May 4, 2026 |
| CMS BALANCE Model documentation (including April 21, 2026 announcement that BALANCE will not be implemented in Medicare Part D) | May 4, 2026 |
| California DMHC Independent Medical Review information (including 2024 Annual Report ~73% IMR success rate) | May 4, 2026 |
| Provider current pricing pages — Ro, Sesame Care, Shapely (getshapely.com/weightloss/insurance/health-net), Form Health, knownwell, PlushCare, WeightWatchers, NovoCare, LillyDirect Zepbound | May 4, 2026 |
| FDA postmarket safety information on unapproved GLP-1 drugs and April 30, 2026 proposal to exclude semaglutide, tirzepatide, and liraglutide from 503B Bulk Drug Substances List | May 4, 2026 |
What we couldn't verify:
- Your exact copay (depends on your specific plan tier and deductible status)
- Whether your specific employer purchased an enhanced GLP-1 benefit rider
- Whether your specific provider is in-network for your specific Health Net plan name
- Whether your PA will be approved (depends on your documentation)
- Coverage rules for Health Net plans outside California
Who wrote this and why
The RX Index Editorial Team. The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We don't manufacture or sell medication, we don't provide medical care, and we don't sell insurance.
This page exists because Health Net members searching “GLP-1 providers that accept Health Net” deserve a real answer — not a thin affiliate listicle that says “Provider X accepts Health Net” without explaining whether that means visit billing, medication coverage, or PA help. We separated those four questions because that's the only way you can pick the right next step.
This page is not medical advice. It is not a substitute for a conversation with your prescriber, your Health Net plan, or a licensed clinician. Affiliate disclosure: The RX Index has affiliate relationships with Ro and Sesame Care. Our recommendations are based on verified coverage-route fit, not payout alone — which is why Shapely is recommended for the in-network-visits use case even though it's not an affiliate partner.
Related guides
- →GLP-1 Providers That Accept UnitedHealthcare
- →GLP-1 Providers That Accept Centene
- →GLP-1 Providers That Accept Humana
- →Best GLP-1 Providers That Accept Insurance
- →Best Zepbound Providers That Accept Insurance
- →Does Ro Take Insurance for Weight Loss?
- →GLP-1 Formulary Exception: How to File One
- →Does Insurance Cover Foundayo?
- →Best Foundayo Providers That Accept Insurance
- →How to Get a GLP-1 Without Insurance
Still not sure which path fits you?
You don't have to figure this out alone. A few short questions — sixty seconds. We send you a personalized action plan with the next step that actually fits your specific Health Net plan, BMI, diagnosis, and goals. Free. No insurance card or medical history required.